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Abstract
Summary: The Illumina Infinium EPIC BeadChip is a new high-throughput array for DNA methylation analysis, 
extending the earlier 450k array by over 400,000 new sites. Previously, a method named eFORGE was developed 
to provide insights into cell type-specific and cell composition effects for 450k data. Here, we present a 
significantly updated and improved version of eFORGE that can analyse both EPIC and 450k array data. New 
features include analysis of chromatin states, TF motifs and DNase I footprints, providing tools for EWAS 
interpretation and epigenome editing.
Availability: eFORGE v2.0 is implemented as a web tool available from https://eforge.altiusinstitute.org and 
https://eforge-tf.altiusinstitute.org/.
Contact: c.breeze@ucl.ac.uk 
Supplementary information: Supplementary data are available at Bioinformatics online.
1 Introduction 
DNA methylation (DNAm) is the main epigenetic mark assayed in the 
study of human diseases. The new EPIC BeadChip developed by Illumina 
can detect DNAm at over 850,000 genomic sites, extending the promoter-
centric coverage of the 450k array to enhancers identified by the ENCODE 
and FANTOM5 projects (ENCODE Project Consortium, 2012) 
(Andersson et al., 2014), constituting a powerful and robust new tool for 
epigenome-wide association studies (Moran et al., 2016).  
The original version of eFORGE (Breeze et al., 2016) employs 
multiple layers of epigenetic information, including data for open 
chromatin sites (DNase I hotspots) and histone marks (H3K4me1, 
H3K4me3, H3K27me3, H3K9me3 and H3K36me3) to detect cell types 
driving EWAS signal.  
© The Author(s) 2019. Published by Oxford University Press. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the 
original work is properly cited. 
D
ow
nloaded from
 https://academ
ic.oup.com
/bioinform
atics/advance-article-abstract/doi/10.1093/bioinform
atics/btz456/5510552 by U
C
L (U
niversity C
ollege London) user on 17 June 2019
C.Breeze et al.
The updated version of eFORGE extends and enhances the tool, 
adding new features such as simultaneous analysis across 15 chromatin 
states, detection of TF motifs associated with EWAS signal, cumulative 
DNase I footprint analysis, EPIC array support, and a browser to analyse 
TF occupancy in EWAS loci. Notably, we incorporate many of these 
features into a new web-based suite, eFORGE-TF, to aid the multilevel 
characterisation of TF-associated EWAS mechanisms.
2 Description
eFORGE v2.0 is a software tool written in Perl and Python. eFORGE takes 
a list of EWAS array probes, and tests them for overlap enrichment with 
epigenetic tracks using an extensive database of 815 individual datasets. 
eFORGE currently includes tracks for DNaseI hotspots, 5 histone marks 
and 15 chromatin states. Probes can be filtered using a 1-kb proximity 
filter, and can be input in either bed or probeid format. Statistical 
enrichment analysis is performed using a binomial test against an array-
specific background. eFORGE outputs key information including 
Benjamini-Yekutieli-corrected p-values, sample IDs and lists of probes 
overlapping tracks in each sample. Both static and interactive charts and 
tables are provided to view results (Fig. 1A).  
Fig. 1.  Output examples of eFORGE v2.0. [A] Enrichment in brain enhancers and TSS 
flanking chromatin states for the top 200 sites from an Illumina EPIC array study (Moran 
et al., 2016). [B] TF motifs with the highest enrichment for the top 1000 study probes, 
including two RFX5 motifs. [C] Distribution of study sites in aggregated RFX5 footprints 
from brain samples shows 6 of the 1000 top study probes overlapping 5 different positions 
within the motif (q-value=0.038, Hypergeometric test, BY correction).
eFORGE chromatin state enrichment analysis extends previous 
eFORGE analyses by breaking down cell type-specific signal into 
regulatory element classes (e.g. subcategories of promoters, enhancers, 
and transcribed regions). Furthermore, the activity of many of these 
classes is known to be associated with the binding of sequence-specific 
transcription factors (TFs). Interestingly, DNAm changes can also result 
as a consequence of the binding of sequence-specific TFs (Smith and 
Meissner, 2013).  
To break down cell type-specific signal into particular TF groups we 
have generated eFORGE-TF, a software suite that allows for TF analysis 
at three levels. First, it analyses the EWAS probe list for TF motif 
enrichment across all known TF motifs (Fig. 1B). This analysis can 
optionally be conditioned to DNase I footprints. Second, eFORGE-TF 
performs a cumulative analysis across an aggregated set of DNase I 
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footprints to visualise DNAm changes in relation to particular basepairs 
of an aggregated footprint (Fig. 1C). Third, eFORGE-TF provides a locus-
specific gallery to inspect individual probes using a combination of TF 
motifs and DNase I footprints. These three analysis levels provide a robust 
and comprehensive assessment of TF associations for a given EWAS 
probe list.   
In each gallery panel, eFORGE-TF includes an interactive browser 
for locus-specific analysis. This browser overlays multiple levels of 
information such as footprints, TF motifs and genomic coordinates, 
providing an in-depth view into the TF associations of a particular locus. 
Such an tool can aid both EWAS interpretation and epigenome editing 
approaches, which can benefit from the characterisation of local TF 
binding sites (Voigt and Reinberg, 2013).  
More details, including an example eFORGE analysis, are available 
(Supplementary Material). 
3 Conclusion
This updated and improved version of eFORGE constitutes an extended 
and powerful tool for the analysis of Illumina EPIC and 450k array data. 
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